Trial Profile
To Evaluate the Efficacy and Safety of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients: a Phase II Single Center Prospective Clinical Trial
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Biomarker; Therapeutic Use
- 23 Jul 2012 New trial record